← Back to feedRead original →
VERIFIEDET Finance·neutral
Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDA
AI Summary
- ·Aurobindo Pharma's US facility in Raleigh received a Voluntary Action Indicated classification from the US FDA.
- ·The US FDA has closed its inspection of the Raleigh manufacturing plant.
- ·The VAI classification permits the progression of applications for inhalers and other products manufactured at the facility.